Human papillomavirus 16 E6 increases the radiosensitivity of p53-mutated cervical cancer cells, associated with up-regulation of aurora A

References

• Chen SS, Chang PC, Cheng YW, Tang FM, Lin YS. 2002. Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function. EMBO Journal 21:4491–4499.
   PubMed Web of Science ®Google Scholar
• Chng WJ, Braggio E, Mulligan G, Bryant B, Remstein E, Valdez R, Dogan A, Fonseca R. 2008. The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition. Blood 111:1603–1609.
   PubMed Web of Science ®Google Scholar
• Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ, Vousden KH. 1992. Clonal p53 mutation in primary cervical cancer: Association with human-papillomavirus-negative tumours. The Lancet 339:1070–1073.
   PubMed Web of Science ®Google Scholar
• Crook T, Wrede D, Vousden KH. 1991. p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 6:873–875.
   PubMed Web of Science ®Google Scholar
• Datta NR, Kumar P, Singh S, Gupta D, Srivastava A, Dhole TN. 2006. Does pretreatment human papillomavirus (HPV) titers predict radiation response and survival outcomes in cancer cervix? A pilot study. Gynecologic Oncology 103:100–105.
   PubMed Web of Science ®Google Scholar
• Feki LA. 2006. Phenotypic features with p53 alterations related to human papillomavirus and prognostic evaluation in cervical cancer. International Journal of Gynecological Cancer 16:708–717.
   PubMed Web of Science ®Google Scholar
• Ferguson BE, Oh DH. 2005. Proficient global nucleotide excision repair in human keratinocytes but not in fibroblasts deficient in p53. Cancer Research 65:8723–8729.
   PubMed Web of Science ®Google Scholar
• Ford JM, Baron EL, Hanawalt PC. 1998. Human fibroblasts expressing the human papillomavirus E6 gene are deficient in global genomic nucleotide excision repair and sensitive to ultraviolet irradiation. Cancer Research 58:599–603.
   PubMed Web of Science ®Google Scholar
• Giampieri S, Storey A. 2004. Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18. British Journal of Cancer 90:2203–2209.
   PubMed Web of Science ®Google Scholar
• Hampson L, El Hady ES, Moore JV, Kitchener H, Hampson IN. 2001. The HPV16 E6 and E7 proteins and the radiation resistance of cervical carcinoma. Faseb Journal 15:1445–1447.
   PubMed Web of Science ®Google Scholar
• Harima Y, Sawada S, Nagata K, Sougawa M, Ohnishi T. 2002. Human papilloma virus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy. International Journal of Radiation Oncology Biology Physics 52:1345–1351.
   PubMed Web of Science ®Google Scholar
• Helland A, Karlsen F, Due EU, Holm R, Kristensen G, Borresen-Dale A. 1998. Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load. British Journal of Cancer 78:69–72.
   PubMed Web of Science ®Google Scholar
• Higgins GD, Davy M, Roder D, Uzelin DM, Phillips GE, Burrell CJ. 1991. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. The Lancet 338:910–913.
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Mitsuhashi N, Sakurai H, Maebayashi K, Niibe H. 2001. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone. Cancer 91:80–89.
   PubMed Web of Science ®Google Scholar
• Kim JY, Kim CH, Stratford IJ, Patterson AV, Hendry JH. 2004. The bioreductive agent RH1 and gamma-irradiation both cause G2/M cell cycle phase arrest and polyploidy in a p53-mutated human breast cancer cell line. Radiation Oncology Biology Physics 58:376–385.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nuñez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G; Nomenclature Committee on Cell Death 2009. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009 Jan;16(1):3–11. Epub 2008 Oct 10.
   PubMed Web of Science ®Google Scholar
• Liu Y, Heilman SA, Illanes D, Sluder G, Chen JJ. 2007. p53-independent abrogation of a postmitotic checkpoint contributes to human papillomavirus E6-induced polyploidy. Cancer Research 67:2603–2610.
   PubMed Web of Science ®Google Scholar
• Lu X, Feki A. 2006. Phenotypic features with p53 alterations related to human papillomavirus and prognostic evaluation in cervical cancer. International Journal of Gynecological Cancer 16:708–717.
   PubMed Web of Science ®Google Scholar
• Marumoto T, Zhang D, Saya H. 2005. Aurora-A – a guardian of poles. Nature Reviews Cancer 5:42–50.
   PubMed Web of Science ®Google Scholar
• Paquette RL, Lee YY, Wilczynski SP, Karmakar A, Kizaki M, Miller CW, Koeffler HP. 1993. Mutations of p53 and human papillomavirus infection in cervical carcinoma. Cancer 72:1272–1280.
   PubMed Web of Science ®Google Scholar
• Riou G, Favre M, Jeannel D, Bourhis J, Le Doussal V, Orth G. 1990. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. The Lancet 335:1171–1174.
   PubMed Web of Science ®Google Scholar
• Sisk EA, Bradford CR, Jacob A, Yian CH, Staton KM, Tang G, Harris MO, Carey TE, Lancaster WD, Gregoire L. 2000. Human papillomavirus infection in ‘young’ versus ‘old’ patients with squamous cell carcinoma of the head and neck. Head and Neck 22:649–657.
   PubMed Web of Science ®Google Scholar
• Sisk EA, Soltys SG, Zhu S, Fisher SG, Carey TE, Bradford CR. 2002. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Head and Neck 24:841–849.
   PubMed Web of Science ®Google Scholar
• Song S, Gulliver GA, Lambert PF. 1998. Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways. Proceedings of the National Academy of Sciences of USA 95:2290–2295.
   PubMed Web of Science ®Google Scholar
• Tao Y, Zhang P, Frascogna V, Lecluse Y, Auperin A, Bourhis J, Deutsch E. 2007. Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cells. British Journal of Cancer 97:1664–1672.
   PubMed Web of Science ®Google Scholar
• Teoh NC, Dan YY, Swisshelm K, Lehman S, Wright JH, Haque J, Gu Y, Fausto N. 2008. Defective DNA strand break repair causes chromosomal instability and accelerates liver carcinogenesis in mice. Hepatology 47:2078–2088.
   PubMed Web of Science ®Google Scholar
• Thompson DA, Belinsky G, Chang TH, Jones DL, Schlegel R, Munger K. 1997. The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints. Oncogene 15:3025–3035.
   PubMed Web of Science ®Google Scholar
• Zhang H, Jin Y, Chen X, Jin C, Law S, Tsao SW, Kwong YL. 2007. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation. Cancer Letters 245:184–194.
   PubMed Web of Science ®Google Scholar